• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Wolverine Asset Management Llc

    1/12/24 12:04:38 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care
    Get the next $ACAX alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    WOLVERINE ASSET MANAGEMENT LLC

    (Last) (First) (Middle)
    175 WEST JACKSON
    SUITE 340

    (Street)
    CHICAGO IL 60604

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    HWH International Inc. [ ACAX ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    Officer (give title below) X Other (specify below)
    Former 10% owner
    3. Date of Earliest Transaction (Month/Day/Year)
    01/10/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 01/10/2024 P 200,165 D $10.66 0 I By Wolverine Asset Management, LLC as manager of Wolverine Flagship Fund Trading Limited
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Kenneth Nadel, Chief Operating Officer 01/12/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ACAX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACAX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ACAX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Wolverine Asset Management Llc

    4 - HWH International Inc. (0001897245) (Issuer)

    1/12/24 12:04:38 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    $ACAX
    SEC Filings

    View All

    SEC Form 8-K filed by Alset Capital Acquisition Corp.

    8-K - HWH International Inc. (0001897245) (Filer)

    2/12/24 9:00:29 AM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    Alset Capital Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Leadership Update, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

    8-K - HWH International Inc. (0001897245) (Filer)

    1/12/24 5:22:46 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    SEC Form 25-NSE filed by Alset Capital Acquisition Corp.

    25-NSE - Alset Capital Acquisition Corp. (0001897245) (Subject)

    1/8/24 5:03:55 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    $ACAX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HWH International together with Alset Capital Acquisition Corp. Announce Closing of Business Combination

    The common stock of the combined company is expected to commence trading on The Nasdaq Global Market under ticker symbol "HWH" on January 9, 2024. Bethesda, MD, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Alset Capital Acquisition Corp. ("Alset") (Nasdaq: "ACAX" for common stock and "ACAXR" for rights), today announced the completion of its previously announced business combination (the "Business Combination"), with HWH International Inc. ("HWH"), a purpose-driven lifestyle company encompassing differentiated offerings from four core pillars: HWH Marketplace, Hapi Cafe, Hapi Travel Destination and Hapi Wealth Builder. The common stock of the combined company is expected to begin trading on The Nasd

    1/8/24 12:20:00 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    Alset Capital Acquisition Corp. Provides Additional Update Regarding Stockholder Redemptions

    Bethesda, MD, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Alset Capital Acquisition Corp. (NASDAQ:ACAX) ("Alset") provided additional updates today regarding stockholder redemptions. Alset currently has 1,911,236 shares of publicly held Class A common stock issued, outstanding and held by non-affiliates (such number of shares does not include any shares of Class A common stock held by Alset's Sponsor and management). Alset has extended the deadline for stockholders to redeem Class A common stock until 5:00 p.m. Eastern Time on Wednesday, September 13, 2023 ("the Revised Deadline"). In addition, stockholders who previously submitted redemption requests may withdraw such previously submitted redemp

    8/23/23 10:52:00 AM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    Alset Capital Acquisition Corp. Provides Additional Update Regarding Stockholder Redemptions

    Bethesda, MD, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Alset Capital Acquisition Corp. (NASDAQ:ACAX) ("Alset") provided additional updates today regarding stockholder redemptions. Alset will be accepting requests by any public stockholder who submitted a request to redeem their Class A common stock prior to the deadline of July 28, 2023 to withdraw such previously submitted redemption requests until 5:00 p.m. Eastern Time on Wednesday, August 23, 2023. Stockholders who wish to withdraw their previously submitted redemption requests may do so by contacting Alset's transfer agent VStock Transfer, LLC at Attn: DWAC team, Email: [email protected]. About Alset Capital Acquisition Corp. Alset

    8/14/23 12:55:00 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    $ACAX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chan Heng Fai Ambrose disposed of 347,220 shares (SEC Form 4)

    4 - HWH International Inc. (0001897245) (Issuer)

    2/1/24 9:45:27 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    New insider Alset Inc. claimed ownership of 13,577,375 shares (SEC Form 3)

    3 - HWH International Inc. (0001897245) (Issuer)

    1/19/24 7:57:05 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    SEC Form 3 filed by new insider Chan Anthony S.

    3 - HWH International Inc. (0001897245) (Issuer)

    1/17/24 6:03:45 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    $ACAX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Alset Capital Acquisition Corp.

    SC 13G - HWH International Inc. (0001897245) (Subject)

    2/14/24 4:59:56 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)

    SC 13G/A - HWH International Inc. (0001897245) (Subject)

    2/14/24 3:30:10 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)

    SC 13G/A - HWH International Inc. (0001897245) (Subject)

    2/14/24 12:26:24 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care